← Back to Search

EMPOWER Intervention for Young Adult Cancer Survivors (MOST EMPOWER Trial)

N/A
Recruiting
Led By John M Salsman, Ph.D
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Past history of a cancer diagnosis (excluding basal cell skin carcinoma)
15 to 39 years of age at diagnosis of first cancer and currently between the ages of 15 to 39
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 4 months after intervention
Awards & highlights

MOST EMPOWER Trial Summary

This trial is testing a digital health intervention to improve wellbeing in young adult cancer survivors. The goal is to learn more about how to promote wellness and manage health-related quality of life among this population.

Who is the study for?
This trial is for young adult cancer survivors, aged 15-39, who were diagnosed with their first cancer at the same age range and are within 0-5 years post-active treatment. Participants must understand English and have internet access. Those hospitalized for psychiatric illness or in palliative/hospice care cannot join.Check my eligibility
What is being tested?
The EMPOWER digital health intervention is being tested to see if it can improve well-being, coping skills, and mood management among young adult cancer survivors. The study aims to enhance overall wellness and quality of life through this online program.See study design
What are the potential side effects?
Since EMPOWER is a digital health intervention focusing on emotional regulation rather than medication or medical procedures, traditional physical side effects are not expected. However, participants may experience emotional discomfort while engaging with the content.

MOST EMPOWER Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had cancer before, but not skin cancer.
Select...
I was diagnosed with my first cancer between 15 and 39 years old and am currently in that age range.

MOST EMPOWER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 4 months after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 4 months after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient-Reported Outcomes Measurement Information System (PROMIS) Positive Affect Computer Adaptive Test (CAT) Questionnaire
Secondary outcome measures
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Questionnaire
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Questionnaire
Patient-Reported Outcomes Measurement Information System (PROMIS) Life Satisfaction Questionnaire

MOST EMPOWER Trial Design

32Treatment groups
Experimental Treatment
Group I: Condition 9Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Mindfulness, 3) Weight Management, 4) Financial Literacy and 5) Sun Protection
Group II: Condition 8Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Diet, 3) Positive Reappraisal , 4) Strengths/ Achievable Goals and 5) Acts of Kindness
Group III: Condition 7Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Diet, 3) Positive Reappraisal , 4) Strengths/ Achievable Goals and 5) Sun Protection
Group IV: Condition 6Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Diet, 3) Positive Reappraisal , 4) Financial Literacy and 5) Acts of Kindness
Group V: Condition 5Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Diet, 3) Positive Reappraisal , 4) Financial Literacy and 5) Sun Protection
Group VI: Condition 4Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Diet, 3) Weight Management, 4) Strengths/ Achievable Goals and 5) Acts of Kindness
Group VII: Condition 32Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Mindfulness, 3) Positive Reappraisal , 4) Strengths/ Achievable Goals and 5) Acts of Kindness
Group VIII: Condition 31Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Mindfulness, 3) Positive Reappraisal , 4) Strengths/ Achievable Goals and 5) Sun Protection
Group IX: Condition 30Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Mindfulness, 3) Positive Reappraisal , 4) Financial Literacy and 5) Acts of Kindness
Group X: Condition 3Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Diet, 3) Weight Management, 4) Strengths/ Achievable Goals and 5) Sun Protection
Group XI: Condition 29Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Mindfulness, 3) Positive Reappraisal , 4) Financial Literacy and 5) Sun Protection
Group XII: Condition 28Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Mindfulness, 3) Weight Management, 4) Strengths/Achievable Goals and 5) Acts of Kindness
Group XIII: Condition 27Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Mindfulness, 3) Weight Management, 4) Strengths/ Achievable Goals and 5) Sun Protection
Group XIV: Condition 26Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Mindfulness, 3) Weight Management, 4) Financial Literacy and 5) Acts of Kindness
Group XV: Condition 25Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Positive Reappraisal , 4) Strengths/ Achievable Goals and 5) Acts of Kindness
Group XVI: Condition 24Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Positive Reappraisal , 4) Strengths/ Achievable Goals and 5) Acts of Kindness
Group XVII: Condition 23Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Positive Reappraisal , 4) Financial Literacy and 5) Sun Protection
Group XVIII: Condition 22Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Positive Reappraisal , 4) Financial Literacy and 5) Acts of Kindness
Group XIX: Condition 21Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Positive Reappraisal , 4) Financial Literacy and 5) Sun Protection
Group XX: Condition 20Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Weight Management, 4) Strengths/ Achievable Goals and 5) Acts of Kindness
Group XXI: Condition 2Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Diet, 3) Weight Management, 4) Financial Literacy and 5) Acts of Kindness
Group XXII: Condition 19Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Weight Management, 4) Strengths/ Achievable Goals and 5) Sun Protection
Group XXIII: Condition 18Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Weight Management, 4) Financial Literacy and 5) Acts of Kindness
Group XXIV: Condition 17Experimental Treatment1 Intervention
1) Positive Events, Capitalizing and Gratitude, 2) Diet, 3) Weight Management, 4) Financial Literacy and 5) Sun Protection
Group XXV: Condition 16Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Mindfulness, 3) Positive Reappraisal , 4) Strengths/ Achievable Goals and 5) Acts of Kindness
Group XXVI: Condition 15Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Mindfulness, 3) Positive Reappraisal , 4) Strengths/ Achievable Goals and 5) Sun Protection
Group XXVII: Condition 14Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Mindfulness, 3) Positive Reappraisal , 4) Financial Literacy and 5) Acts of Kindness
Group XXVIII: Condition 13Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Mindfulness, 3) Positive Reappraisal , 4) Financial Literacy and 5) Sun Protection
Group XXIX: Condition 12Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Mindfulness, 3) Weight Management, 4) Strengths/ Achievable Goals and 5) Acts of Kindness
Group XXX: Condition 11Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Mindfulness, 3) Weight Management, 4) Strengths/ Achievable Goals and 5) Sun Protection
Group XXXI: Condition 10Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Mindfulness, 3) Weight Management, 4) Financial Literacy and 5) Acts of Kindness
Group XXXII: Condition 1Experimental Treatment1 Intervention
1) Cognitive Changes after Cancer, 2) Diet, 3) Weight Management, 4) Financial Literacy and 5) Sun Protection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EMPOWER
2022
N/A
~130

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,234 Previous Clinical Trials
1,001,705 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,626 Previous Clinical Trials
40,927,283 Total Patients Enrolled
John M Salsman, Ph.DPrincipal InvestigatorWake Forest University Health Sciences

Media Library

EMPOWER Clinical Trial Eligibility Overview. Trial Name: NCT04317417 — N/A
Cancer Research Study Groups: Condition 13, Condition 7, Condition 18, Condition 10, Condition 4, Condition 17, Condition 16, Condition 8, Condition 1, Condition 15, Condition 5, Condition 31, Condition 9, Condition 24, Condition 26, Condition 22, Condition 23, Condition 6, Condition 19, Condition 11, Condition 3, Condition 27, Condition 30, Condition 29, Condition 32, Condition 2, Condition 12, Condition 14, Condition 21, Condition 28, Condition 25, Condition 20
Cancer Clinical Trial 2023: EMPOWER Highlights & Side Effects. Trial Name: NCT04317417 — N/A
EMPOWER 2023 Treatment Timeline for Medical Study. Trial Name: NCT04317417 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial accepting elderly participants?

"According to the requirements outlined in this clinical trial's inclusion criteria, only those aged between 15 and 39 are eligible for participation."

Answered by AI

Are there any remaining openings to participate in this research?

"Confirmed, the information hosted on clinicaltrials.gov indicates that this medical trial is actively seeking participants. This study was first posted on January 6th 2022 and was most recently updated June 14th 2022; 352 patients are required between two locations to complete enrollment."

Answered by AI

What is the intake capacity for this scientific experiment?

"Indeed, the public record on clinicaltrials.gov attests to this medical trial being actively enrolled with 352 individuals needed at two centres. This project was initially logged on January 6th 2022 and underwent its latest amendment on June 14th 2022."

Answered by AI

To what demographic is recruitment for this experiment accessible?

"The enrollment criteria for this medical trial requires that prospective participants are between 15-39 years old and have a malignant tumor. Approximately 352 individuals need to be recruited."

Answered by AI
~57 spots leftby Sep 2024